Obesity, polycystic ovary syndrome and anovulation - how are they interrelated?

Simple item page
dc.contributor.authorNorman, R.
dc.date.issued2001
dc.description.abstractPolycystic ovary syndrome remains a mystery with respect to its aetiology, consequences and management. There is an increasing emphasis on its familial origins although the genes involved are unknown. There are significant changes in risk profiles for cardiovascular disease but no clear clinical evidence of morbidity or mortality. There is evidence of improvement in insulin resistance or insulin sensitivity drugs but uncertainty about improvement in pregnancy outcomes. This review looks at the latest advances in understanding polycystic ovary syndrome, particularly in obesity
dc.description.statementofresponsibilityRobert J. Norman
dc.identifier.citationCurrent Opinion in Obstetrics and Gynecology, 2001; 13(3):323-327
dc.identifier.doi10.1097/00001703-200106000-00013
dc.identifier.issn1040-872X
dc.identifier.issn1473-656X
dc.identifier.orcidNorman, R. [0000-0002-3118-3896]
dc.identifier.urihttp://hdl.handle.net/2440/8131
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.rights© 2001 Lippincott Williams & Wilkins, Inc.
dc.source.urihttp://journals.lww.com/co-obgyn/pages/articleviewer.aspx?year=2001&issue=06000&article=00013&type=abstract
dc.subjectPolycystic ovary syndrome
dc.subjectanovulation
dc.subjectobesity
dc.titleObesity, polycystic ovary syndrome and anovulation - how are they interrelated?
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Obstetrics and Gynaecology publications